microRNAs and mRNAs genes associated with the development of ischemic heart disease
250 44
Keywords:
miRNA, mRNA, binding sites, target genes, ischemic heart disease.Abstract
There was studied the characteristics of interaction of microRNAs with mRNAs of genes, involved in the development of ischemic heart disease. There was identified the 268 binding sites for 2564 miRNA in mRNA of 187 genes, participating in the development of IHD. Among them, 52 arranged in CDS, 23 in 5´UTR and 193 are in 3´UTR. From the database of miRNAs, participating in the development if IHD, there are no miRNA have binding sites in mRNA of 187 genes. mRNA of 44 genes have only one binding site of miRNA. mRNA of ANGPTL2, C3 and IGFBP3 genes bind with miR-1272. miR-1285-5p has binding sites in FGF2 and MMP2 genes. The ΔG/ΔGm value, characterizing the interaction of miRNA with mRNA of stidied genes is equal to 90-95%. Only the interaction of miR-1273g-3p with mRNA of FCGR2A gene is associated with the ΔG/ΔGm value equal to 98%. The obtained data allow to recommend for diagnosis of IHD: associations of miR-1272 with ANGPTL2, C3 and IGFBP3 genes; association of miR-1285-5p with FGF2 and MMP2 genes. miR-3960 has multiple binding sites in mRNA of DAB2IP gene and could be used as a diagnostic marker of IHD. Over five miRNA binds with mRNA of IGF1, MTHFR, PLA2G7 genes. Over six miRNA binds with mRNA of AS3MT, F2RL3,IL6R, MLXIPL, PPP1R3B and TGFB1 genes. Over seven miRNA binds with mRNA of LDLR and NPC1L1 genes. The nine miRNA binds with mRNA of IL6R gene that indicates a strong dependence on the expression of these genes from miRNA. The expression of many genes is dependent on the unique miRNAs: miR-619-5р has 14 target genes; miR-5095 and miR-5096 have 10 target genes. The family of miR-1273a,c,d,e,f,g,h have 38 binding sites including 19 binding sites of miR-1273g-3p in mRNA of 17 genes. mRNA of genes of interleukins IL10, IL18, IL6R with high degree binds with a group of unique miRNAs: miR-619-5р, miR-5095 and miR-5096. In mRNA of several genes presented binding sites with miR-619-5р, miR-5585-3p. mRNA of NOS1 gene contains binding sites for miR-619-5p, miR-5095, miR-1273g-3p, miR-574-5p and miR-466. miR-466 has multiple binding sites in ICAM1, TNFSF4, MLXIPL and PLA2G7 genes. miR-574-5p has multiple binding sites in IGF1 and PPARA genes. Some associations of miRNA with mRNA have a higher free energy of interaction (ΔG). miR-1273d consisting from 25 n. binds with mRNA of SMARCA4 gene with ΔG value equal to -125 kJ/mole, miR-762 consisting from 22 n. binds with mRNA of CSMD1 gene with ΔG value equal to -127 kJ/mole. miR-6789-5p consisting from 24 n. binds with mRNA of FADS3 and HIF1Agenes with ΔG value equal to -129 kJ/mole and 132 kJ/mole. miR-6089-5p consisting from 24 n. binds with mRNA of TGFB1gene in two binding sites with ΔG value equal to -132 kJ/mole and 136 kJ/mole. The same miRNA binds with mRNA of IL6R gene with ΔG value equal to -138 kJ/mole that makes 93% from maximum free energy of binding.
References
Литература
1 Trenkwalder T., Kessler T., Schunkert H., Erdmann J. Genetics of coronary artery disease: Short people at risk? // Expert Review of Cardiovascular Therapy.- 2015.- V.13(11).- P.1169-1172.
2 Arbour L., Asuri S., Whittome B., Polanco F., Hegele RA. The Genetics of Cardiovascular Disease in Canadian and International Aboriginal Populations // Can J Cardiol.- 2015.- V.31(9).- P.1094-1115.
3 Brænne I., Civelek M., Vilne B. Prediction of Causal Candidate Genes in Coronary Artery Disease Loci // Arteriosclerosis, Thrombosis, and Vascular Biology.- 2015.- V.35(10).- P.2207-2217.
4 Hamrefors V. Common genetic risk factors for coronary artery disease: new opportunities for prevention? // Clin Physiol Funct I.- 2015.- V.17.- P.128-141.
5 Cole C.B., Nikpay M., Stewart A.F., McPherson R. Increased genetic risk for obesity in premature coronary artery disease // Eur J Hum Genet.- 2016.- V.29.- P.53-69.
6 Yamada Y., Matsui K., Takeuchi I., Fujimaki T. Association of genetic variants with coronary artery disease and ischemic stroke in a longitudinal population-based genetic epidemiological study // Biomedical Reports.- 2015.- V.3(3).- P.413-419.
7 Ozaki K., Tanaka T. Molecular genetics of coronary artery disease // J Hum Genet.- 2016.- V.61.- P.71–77.
8 Neelankavil J., Rau C.D., Wang Y. The Genetic Basis of Coronary Artery Disease and Atrial Fibrillation: A Search for Disease Mechanisms and Therapeutic Targets // J Cardiothor Vasc An.- 2015.- V.29(5).- P.1328-1332.
9 Hernesniemi J.A., Lyytikäinen L.P., Oksala N., et al. Predicting sudden cardiac death using common genetic risk variants for coronary artery disease // Eur Heart J.- 2015.- V.36(26).- P.1669-1675.
10 Cheng Y., An B., Jiang M., Xin Y., Xuan S. Association of Tumor Necrosis Factor-alpha Polymorphisms and Risk of Coronary Artery Disease in Patients With Non-alcoholic Fatty Liver Disease // Hepat Mon. – 2015.- V.15(3).- P.e26818.
11 Liao B., Cheng K., Dong S., Liu H., Xu Z. Effect of apolipoprotein A1 genetic polymorphisms on lipid profiles and the risk of coronary artery disease // Diagn Pathol.- 2015.- V.10.- P.102.
12 Cui F., Li K., Li Y., Zhang X., An C. Apolipoprotein C3 genetic polymorphisms are associated with lipids and coronary artery disease in a Chinese population // Lipids Health Dis.- 2014.- V.13.- P.170.
13 Arslan S., Korkmaz Ö., Özbilüm N., Berkan Ö. Association between NF-κBI and NF-κBIA polymorphisms and coronary artery disease // Biomedical Reports.- 2015.- V.3(5).- P.736-740.
14 Ahmadi Z., Senemar S., Toosi S., Radmanesh S. The Association of Lipoprotein Lipase Genes, HindIII and S447X Polymorphisms With Coronary Artery Disease in Shiraz City // Jounal of Cardiovascular and Thoracic Research.- 2015.- V.7(2).- P.63-67.
15 Xiao J., Luo X., Lin H., Zhang Y., Lu Y., Wang N., Zhang Y., Yang B., Wang Z. MicroRNA miR-133 represses HERG K+ channel expression contributing to QT prolongation in diabetic hearts // J Biol Chem.- 2011.- V.282(17).- P.12363-12367.
16 Shan H., Zhang Y., Cai B., et al. Upregulation of microRNA-1 and microRNA-133 contributes to arsenic-induced cardiac electrical remodeling // Int J Cardiol.- 2013.- V.167(6).- P.2798-2805.
17 Luo X., Lin H., Pan Z., Xiao J., Zhang Y., Lu Y., Yang B., Wang Z. Down-regulation of miR-1/miR-133 contributes to re-expression of pacemaker channel genes HCN2 and HCN4 in hypertrophic heart // J Biol Chem.- 2008.- V.283(29).- P.20045-20052.
18 Wang N., Zhou Z., Liao X., Zhang T. Role of microRNAs in cardiac hypertrophy and heart failure // International Union of Biochemistry and Molecular Biology Life.- 2009.- V.61(6).- P.566-571.
19 Ye Y., Perez-Polo J.R., Qian J., Birnbaum Y. The role of microRNA in modulating myocardial ischemia-reperfusion injury // Physiol Genomics.- 2011.- V.43(10).- P.534-542.
20 Ono K., Kuwabara Y., Han J. MicroRNAs and cardiovascular diseases // FEBS J.- 2011.- V.278(10).- P.1619-1633.
21 Papoutsidakis N., Deftereos S., Kaoukis A., Bouras G., Giannopoulos G., Theodorakis A., Angelidis C., Hatzis G., Stefanadis C. MicroRNAs and the heart: small things do matter // Curr Top Med Chem.- 2013.- V.13(2).- P.216-230.
22 Camm A.J., Luscher T.F., Serruys P. The ESC Textbook of Cardiovascular Medicine, second edition. Oxford Academy, Great Britain. – 2009. – 100с.
23 Аулик И.В. Определение физической работоспособности в клинике и спорте. – Москва: Медицина.- 1990. – 191с.
24 Бабушкина Г.В., Картелишев А.В. Низкоинсенсивная лазерная терапия. – Москва: «Техника». -2015.- 50с.
25 Paciaroni M., Bogousslavsky J. How did stroke become of interest to neurologists?: a slow 19th century saga // Neurology.- 2009.- V.73(9).- P.724-728.
26 Subramaniam A., Shanmugam M.K., Perumal E., Li F., Nachiyappan A., Dai X., Swamy S.N., Ahn K.S., Kumar A.P., Tan B.K., Hui K.M., Sethi G. Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma // Biochim Biophys Acta.- 2013.- V.1835(1).- P.46-60.
27 Батищева Е.И., Кузнецов Е.И. Современные методы хирургической вторичной профилактики ишемического инсульта // Вестник национального медико-хирургического центра им. Н.И.Пирогова.- 2008.- № 3(2).- С.83-88.
28 O'Gara P.T., Kushner F.G., Ascheim D.D., Casey D.E., Chung M.K., Lemos J.A., Ettinger S.M., Fang J.C., Fesmire F.M., Franklin B.A. ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation // Journal of American College of Cardiology.- 2013.- V.61(4).- P.e78-e140.
29 Roffi M., Patrono C., Collet J.P., et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC) // Eur Heart J.- 2015.- V.37(3).- P.267-315.
30 Всероссийское научное общество кардиологов. Кардиоваскулярная профилактика // Приложение 2 к журналу Кардиоваскулярная терапия профилактика. - 2011.- №10(6).- С.1-64.
31 Xin Y., Yang C., Han Z. Circulating miR-499 as a potential biomarker for acute myocardial infarction // Annual of Translational Medicine.- 2015.- V.4(7).- P.135.
32 Samanta S., Balasubramanian S., Rajasingh S., Patel U., Dhanasekaran A., Dawn B., Rajasingh J. MicroRNA: A new therapeutic strategy for cardiovascular diseases // Trends Cardiovas Med.- 2016.- V.26(5).- P.407-419.
33 Chaturvedi A., Martz R., Dorward D., Waisberg M., Pierce S.K. Endocytosed BCRs sequentially regulate MAPK and Akt signaling pathways from intracellular compartments // Natural Immunology.- 2011.- V.12(11).- P.1119-1126.
34 Li Y., Li A., Yang Z.Q. Molecular cloning, genomic organization, chromosome mapping, tissues expression pattern and identification of a novel splicing variant of porcine CIDEb gene // Biochem Biophys Res Commun.- 2016.- V.1.- P.S0006-291X(16)30778-1.
35 Ai J., Zhang R., Li Y., Pu J., Lu Y., Jiao J. Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction // Biochem Biophys Res Commun.- 2010.- V.391(1).- P.73-77.
36 Alessandra Y.D., Devanna P., Limana F., Straino S., Carlo A.D., Brambilla P.G. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction // Eur Heart J.- 2010.- V.31(22).- P.2765-2773.
37 Yin C., Salloum F.N., Kukreja R.C. A novel role of microRNA in late preconditioning: upregulation of endothelial nitric oxide synthase and heat shock protein 70 // Circ Res.- 2009.- V.104(5).- P.572-575.
38 Иващенко А.Т., Атамбаева Ш.А., Ниязова Р.Е., Пинский И.В. Гены, связанные с развитием ишемической болезни сердца // Вестник КазНУ, серия биологическая.- 2015.- №3 (65). - C. 100-108.
39 Ivashchenko A., Berillo O., Pyrkova A., Niyazova R. Binding Sites of miR-1273 Family on the mRNA of Target Genes // Biomed Research International.- 2014.- V.2014.- P.1-11.
40 Ivashchenko A., Berillo O., Pyrkova A., Niyazova R., Atambayeva S. The properties of binding sites of miR-619-5p, miR-5095, miR-5096 and miR-5585-3p in the mRNAs of human genes // Biomed Research International.- 2014.- V.2014.- P.1-8.
41 Ivashchenko A., Berillo O., Pyrkova A., Niyazova R., Atambayeva S. MiR-3960 binding sites with mRNA of human genes // Bioinformation.- 2014.- V.10(7).- P.423-427.
42 Ivashchenko A., Berillo O., Pyrkova A., Niyazova R., Atambayeva S. The binding sites of unique miRNAs in the human mRNAs // Journal of Biotechnology.- 2014.- V.185S.- P.S37–S125.
43 Атамбаева С., Ниязова Р.Е., Берилло О., Иващенко А.Т. Особенности сайтов связывания mir-574-5р и mir-574-3р с mrna генов-мишеней // Вестник КазНУ, биологическая серия.- 2015.- №1(63).- С.349-354.
References
1 Trenkwalder T, Kessler T, Schunkert H, Erdmann J (2015) Genetics of coronary artery disease: Short people at risk?, Expert Review of Cardiovascular Therapy, 13(11):1169-1172. DOI: 10.1586/14779072.2015.1094377
2 Arbour L, Asuri S, Whittome B, Polanco F, Hegele RA (2015) The Genetics of Cardiovascular Disease in Canadian and International Aboriginal Populations, Can J Cardiol, 31(9):1094-1115. DOI: 10.1016/j.cjca.2015.07.005
3 Brænne I, Civelek M, Vilne B (2015) Prediction of Causal Candidate Genes in Coronary Artery Disease Loci, Arteriosclerosis, Thrombosis, and Vascular Biology, 35(10):2207-2217. DOI: 10.1161/ATVBAHA.115.306108
4 Hamrefors V (2015) Common genetic risk factors for coronary artery disease: new opportunities for prevention?, Clin Physiol Funct I, 17:128-141. DOI: 10.1111/cpf.12289
5 Cole CB, Nikpay M, Stewart AF, McPherson R (2016) Increased genetic risk for obesity in premature coronary artery disease, Eur J Hum Genet, 29:53-69. DOI: 10.1038/ejhg.2015.162
6 Yamada Y, Matsui K, Takeuchi I, Fujimaki T (2015) Association of genetic variants with coronary artery disease and ischemic stroke in a longitudinal population-based genetic epidemiological study, Biomedical Reports, 3(3):413-419. DOI: 10.3892/br.2015.440.
7 Ozaki K, Tanaka T (2016) Molecular genetics of coronary artery disease, J Hum Genet , 61: 71–77. DOI:10.1038/jhg.2015.70
8 Neelankavil J, Rau CD, Wang Y (2015) The Genetic Basis of Coronary Artery Disease and Atrial Fibrillation: A Search for Disease Mechanisms and Therapeutic Targets, J Cardiothor Vasc An, 29(5):1328-1332. DOI: 10.1053/j.jvca.2015.01.031
9 Hernesniemi JA, Lyytikäinen LP, Oksala N, Seppälä I, Kleber ME, Mononen N, März W, Mikkelsson J, Pessi T, Louhelainen AM, Martiskainen M, Nikus K, Klopp N, Waldenberger M, Illig T, Kähönen M, Laaksonen R, Karhunen PJ, Lehtimäki T (2015) Predicting sudden cardiac death using common genetic risk variants for coronary artery disease, Eur Heart J, 36(26):1669-1675. DOI: 10.1093/eurheartj/ehv106
10 Cheng Y, An B, Jiang M, Xin Y, Xuan S (2015) Association of Tumor Necrosis Factor-alpha Polymorphisms and Risk of Coronary Artery Disease in Patients With Non-alcoholic Fatty Liver Disease, Hepat Mon, 15(3):e26818. DOI: 10.5812/hepatmon.26818
11 Liao B, Cheng K, Dong S, Liu H, Xu Z (2015) Effect of apolipoprotein A1 genetic polymorphisms on lipid profiles and the risk of coronary artery disease, Diagn Pathol, 10:102. DOI: 10.1186/s13000-015-0328-7
12 Cui F, Li K, Li Y, Zhang X, An C (2014) Apolipoprotein C3 genetic polymorphisms are associated with lipids and coronary artery disease in a Chinese population, Lipids Health Dis, 13:170. DOI: 10.1186/1476-511X-13-170
13 Arslan S, Korkmaz Ö, Özbilüm N, Berkan Ö (2015) Association between NF-κBI and NF-κBIA polymorphisms and coronary artery disease, Biomedical Reports, 3(5):736-740. DOI: 10.3892/br.2015.499
14 Ahmadi Z, Senemar S, Toosi S, Radmanesh S (2015) The Association of Lipoprotein Lipase Genes, HindIII and S447X Polymorphisms With Coronary Artery Disease in Shiraz City, Jounal of Cardiovascular and Thoracic Research, 7(2):63-67. DOI: 10.15171/jcvtr.2015.14
15 Xiao J, Luo X, Lin H, Zhang Y, Lu Y, Wang N, Zhang Y, Yang B, Wang Z (2011) MicroRNA miR-133 represses HERG K+ channel expression contributing to QT prolongation in diabetic hearts, J Biol Chem, 282(17):12363-12367. DOI: 10.1074/jbc.C700015200
16 Shan H, Zhang Y, Cai B, Chen X, Fan Y, Yang L, Chen X, Liang H, Zhang Y, Song X, Xu C, Lu Y, Yang B, Du Z (2013) Upregulation of microRNA-1 and microRNA-133 contributes to arsenic-induced cardiac electrical remodeling, Int J Cardiol, 167(6):2798-2805. DOI: 10.1016/j.ijcard.2012.07.009
17 Luo X, Lin H, Pan Z, Xiao J, Zhang Y, Lu Y, Yang B, Wang Z (2008) Down-regulation of miR-1/miR-133 contributes to re-expression of pacemaker channel genes HCN2 and HCN4 in hypertrophic heart, J Biol Chem, 283(29):20045-20052. DOI: 10.1074/jbc.M801035200
18 Wang N, Zhou Z, Liao X, Zhang T (2009) Role of microRNAs in cardiac hypertrophy and heart failure, International Union of Biochemistry and Molecular Biology Life, 61(6):566-571. DOI: 10.1002/iub.204
19 Ye Y, Perez-Polo JR, Qian J, Birnbaum Y (2011) The role of microRNA in modulating myocardial ischemia-reperfusion injury, Physiol Genomics, 43(10):534-542. DOI: 10.1152/physiolgenomics.00130.2010
20 Ono K, Kuwabara Y, Han J (2011) MicroRNAs and cardiovascular diseases, FEBS J, 278(10):1619-1633. DOI: 10.1111/j.1742-4658.2011.08090.x
21 Papoutsidakis N, Deftereos S, Kaoukis A, Bouras G, Giannopoulos G, Theodorakis A, Angelidis C, Hatzis G, Stefanadis C (2013) MicroRNAs and the heart: small things do matter, Curr Top Med Chem, 13(2):216-230. DOI: 10.2174/1568026611313020009
22 Camm AJ, Luscher TF, Serruys P (2009) The ESC Textbook of Cardiovascular Medicine, second edition. Oxford Academy, Great Britain. ISBN: 0-19-956699-2
23 Aulik IV (1990) The determination of physical working capacity in clinic and sport [Opredelenie fizicheskoi rabotosposobnosti v klinike i sporte]. Medicina, Moscow, Russia. (In Russian)
24 Babushkina GV, Kartelishev AV (2015) Low-intensive laser therapy [Nizkointensivnaia lazernaia terapiia]. «Tekhnika», Moscow. (In Russian)
25 Paciaroni M, Bogousslavsky J (2009) How did stroke become of interest to neurologists?: a slow 19th century saga, Neurology, 73(9):724-728. DOI: 10.1212/WNL.0b013e3181b59c1a
26 Subramaniam A, Shanmugam M K, Perumal E, Li F, Nachiyappan A, Dai X, Swamy SN, Ahn KS, Kumar AP, Tan BK, Hui KM, Sethi G (2013) Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma, Biochim Biophys Acta, 1835(1):46-60. DOI: 10.1016/j.bbcan.2012.10.002
27 Batishcheva EI, Kuznetsov AN (2008) Modern methods of surgical secondary prevention of ischemic stroke. Journal of N. I. Pirogov’s National Medical and Surgical Center [Sovremennye metody hirurgicheskoi vtorichnoi profilaktici ishemicheskogo insulta. Vestnik Natsional'nogo mediko-khirurgicheskogo tsentra imeni N. I. Pirogova] 3(2):83-88. (In Russian)
28 O'Gara PT, Kushner FG, Ascheim DD, Casey DE, Chung MK, Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA (2013) ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation, Journal of American College of Cardiology, 61(4):e78-e140. DOI:10.1016/j.jacc.2012.11.019
29 Roffi M, Patrono C, Collet JP, et al (2015) ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Eur Heart J, 37(3):267-315. DOI: 10.1093/eurheartj/ehv320
30 Vserossiiskoe nauchnoe obshchestvo kardiologov (2011) Cardiovascular profilactic. Supplement 2 to the journal «Cardiovascular terapy and profilactic» [Kardiovascular profilactika. Prilozheniye k zhurnalu “Serdechno-sosudistaya terapiya I profilactika] 10(6):1-64. (In Russian)
31 Xin Y, Yang C, Han Z (2016) Circulating miR-499 as a potential biomarker for acute myocardial infarction, Annual of Translational Medicine, 4(7):135. DOI: 10.21037/atm.2016.03.40
32 Samanta S, Balasubramanian S, Rajasingh S, Patel U, Dhanasekaran A, Dawn B, Rajasingh J (2016) MicroRNA: A new therapeutic strategy for cardiovascular diseases, Trends Cardiovas Med, 26(5):407-19. DOI: 10.1016/j.tcm.2016.02.004
33 Chaturvedi A, Martz R, Dorward D, Waisberg M, Pierce SK (2011) Endocytosed BCRs sequentially regulate MAPK and Akt signaling pathways from intracellular compartments, Natural Immunology, 12(11):1119-1126. DOI: 10.1038/ni.2116
34 Li Y, Li A, Yang ZQ (2016) Molecular cloning, genomic organization, chromosome mapping, tissues expression pattern and identification of a novel splicing variant of porcine CIDEb gene, Biochem Biophys Res Commun, 1:S0006-291X(16)30778-1. DOI: 10.1016/j.bbrc.2016.05.079
35 Ai J, Zhang R, Li Y, Pu J, Lu Y, Jiao J (2010) Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction, Biochem Biophys Res Commun, 391(1):73-77. DOI: 10.1016/j.bbrc.2009.11.005
36 Alessandra YD, Devanna P, Limana F, Straino S, Carlo AD, Brambilla PG (2010) Circulating microRNAs are new and sensitive biomarkers of myocardial infarction, Eur Heart J, 31(22):2765-2773. DOI: 10.1093/eurheartj/ehq167
37 Yin C, Salloum FN, Kukreja RC (2009) A novel role of microRNA in late preconditioning: upregulation of endothelial nitric oxide synthase and heat shock protein 70, Circ Res, 104(5):572-575. DOI: 10.1161/CIRCRESAHA.108.193250
38 Ivashchenko A, Atambayeva S, Niyazova R, Pinsky I (2015) Genes associated with the development of of coronary heart disease. Vestnik KazNU, biological series [Geny svyazannye s razvitiem ishemicheskoi bolezni serdtca. Vestnik KazNU, biologicheskaya seriya] 3(65):100-108. (In Russian)
39 Ivashchenko A, Berillo O, Pyrkova A, Niyazova R (2014) Binding Sites of miR-1273 Family on the mRNA of Target Genes, Biomed Research International, 2014:1-11. DOI:10.1155/2014/620530
40 Ivashchenko A, Berillo O, Pyrkova A, Niyazova R, Atambayeva S (2014) The properties of binding sites of miR-619-5p, miR-5095, miR-5096 and miR-5585-3p in the mRNAs of human genes, Biomed Research International, 2014:1-8. DOI: 10.1155/2014/720715
41 Ivashchenko A, Berillo O, Pyrkova A, Niyazova R, Atambayeva S (2014) MiR-3960 binding sites with mRNA of human genes, Bioinformation, 10(7):423-427. DOI: 10.6026/97320630010423
42 Ivashchenko A, Berillo O, Pyrkova A, Niyazova R, Atambayeva S (2014) The binding sites of unique miRNAs in the human mRNAs, Journal of Biotechnology, 185S:S37–S125. DOI: 10.1016/j.jbiotec.2014.07.181
43 Atambayeva S, Niyazova R, Berillo O, Ivashchenko A (2015) Features of binding sites of miR-574-5p and miR-574-3p with mRNA of target genes. Vestnik KazNU, biological series [Osobennosti saitov svyazyvaniya miR-574-5р i miR-574-3р s mRNA genov-mishenei. Vestnik KazNU, biologicheskaya seriya] 1(63):349-354. (In Russian)
1 Trenkwalder T., Kessler T., Schunkert H., Erdmann J. Genetics of coronary artery disease: Short people at risk? // Expert Review of Cardiovascular Therapy.- 2015.- V.13(11).- P.1169-1172.
2 Arbour L., Asuri S., Whittome B., Polanco F., Hegele RA. The Genetics of Cardiovascular Disease in Canadian and International Aboriginal Populations // Can J Cardiol.- 2015.- V.31(9).- P.1094-1115.
3 Brænne I., Civelek M., Vilne B. Prediction of Causal Candidate Genes in Coronary Artery Disease Loci // Arteriosclerosis, Thrombosis, and Vascular Biology.- 2015.- V.35(10).- P.2207-2217.
4 Hamrefors V. Common genetic risk factors for coronary artery disease: new opportunities for prevention? // Clin Physiol Funct I.- 2015.- V.17.- P.128-141.
5 Cole C.B., Nikpay M., Stewart A.F., McPherson R. Increased genetic risk for obesity in premature coronary artery disease // Eur J Hum Genet.- 2016.- V.29.- P.53-69.
6 Yamada Y., Matsui K., Takeuchi I., Fujimaki T. Association of genetic variants with coronary artery disease and ischemic stroke in a longitudinal population-based genetic epidemiological study // Biomedical Reports.- 2015.- V.3(3).- P.413-419.
7 Ozaki K., Tanaka T. Molecular genetics of coronary artery disease // J Hum Genet.- 2016.- V.61.- P.71–77.
8 Neelankavil J., Rau C.D., Wang Y. The Genetic Basis of Coronary Artery Disease and Atrial Fibrillation: A Search for Disease Mechanisms and Therapeutic Targets // J Cardiothor Vasc An.- 2015.- V.29(5).- P.1328-1332.
9 Hernesniemi J.A., Lyytikäinen L.P., Oksala N., et al. Predicting sudden cardiac death using common genetic risk variants for coronary artery disease // Eur Heart J.- 2015.- V.36(26).- P.1669-1675.
10 Cheng Y., An B., Jiang M., Xin Y., Xuan S. Association of Tumor Necrosis Factor-alpha Polymorphisms and Risk of Coronary Artery Disease in Patients With Non-alcoholic Fatty Liver Disease // Hepat Mon. – 2015.- V.15(3).- P.e26818.
11 Liao B., Cheng K., Dong S., Liu H., Xu Z. Effect of apolipoprotein A1 genetic polymorphisms on lipid profiles and the risk of coronary artery disease // Diagn Pathol.- 2015.- V.10.- P.102.
12 Cui F., Li K., Li Y., Zhang X., An C. Apolipoprotein C3 genetic polymorphisms are associated with lipids and coronary artery disease in a Chinese population // Lipids Health Dis.- 2014.- V.13.- P.170.
13 Arslan S., Korkmaz Ö., Özbilüm N., Berkan Ö. Association between NF-κBI and NF-κBIA polymorphisms and coronary artery disease // Biomedical Reports.- 2015.- V.3(5).- P.736-740.
14 Ahmadi Z., Senemar S., Toosi S., Radmanesh S. The Association of Lipoprotein Lipase Genes, HindIII and S447X Polymorphisms With Coronary Artery Disease in Shiraz City // Jounal of Cardiovascular and Thoracic Research.- 2015.- V.7(2).- P.63-67.
15 Xiao J., Luo X., Lin H., Zhang Y., Lu Y., Wang N., Zhang Y., Yang B., Wang Z. MicroRNA miR-133 represses HERG K+ channel expression contributing to QT prolongation in diabetic hearts // J Biol Chem.- 2011.- V.282(17).- P.12363-12367.
16 Shan H., Zhang Y., Cai B., et al. Upregulation of microRNA-1 and microRNA-133 contributes to arsenic-induced cardiac electrical remodeling // Int J Cardiol.- 2013.- V.167(6).- P.2798-2805.
17 Luo X., Lin H., Pan Z., Xiao J., Zhang Y., Lu Y., Yang B., Wang Z. Down-regulation of miR-1/miR-133 contributes to re-expression of pacemaker channel genes HCN2 and HCN4 in hypertrophic heart // J Biol Chem.- 2008.- V.283(29).- P.20045-20052.
18 Wang N., Zhou Z., Liao X., Zhang T. Role of microRNAs in cardiac hypertrophy and heart failure // International Union of Biochemistry and Molecular Biology Life.- 2009.- V.61(6).- P.566-571.
19 Ye Y., Perez-Polo J.R., Qian J., Birnbaum Y. The role of microRNA in modulating myocardial ischemia-reperfusion injury // Physiol Genomics.- 2011.- V.43(10).- P.534-542.
20 Ono K., Kuwabara Y., Han J. MicroRNAs and cardiovascular diseases // FEBS J.- 2011.- V.278(10).- P.1619-1633.
21 Papoutsidakis N., Deftereos S., Kaoukis A., Bouras G., Giannopoulos G., Theodorakis A., Angelidis C., Hatzis G., Stefanadis C. MicroRNAs and the heart: small things do matter // Curr Top Med Chem.- 2013.- V.13(2).- P.216-230.
22 Camm A.J., Luscher T.F., Serruys P. The ESC Textbook of Cardiovascular Medicine, second edition. Oxford Academy, Great Britain. – 2009. – 100с.
23 Аулик И.В. Определение физической работоспособности в клинике и спорте. – Москва: Медицина.- 1990. – 191с.
24 Бабушкина Г.В., Картелишев А.В. Низкоинсенсивная лазерная терапия. – Москва: «Техника». -2015.- 50с.
25 Paciaroni M., Bogousslavsky J. How did stroke become of interest to neurologists?: a slow 19th century saga // Neurology.- 2009.- V.73(9).- P.724-728.
26 Subramaniam A., Shanmugam M.K., Perumal E., Li F., Nachiyappan A., Dai X., Swamy S.N., Ahn K.S., Kumar A.P., Tan B.K., Hui K.M., Sethi G. Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma // Biochim Biophys Acta.- 2013.- V.1835(1).- P.46-60.
27 Батищева Е.И., Кузнецов Е.И. Современные методы хирургической вторичной профилактики ишемического инсульта // Вестник национального медико-хирургического центра им. Н.И.Пирогова.- 2008.- № 3(2).- С.83-88.
28 O'Gara P.T., Kushner F.G., Ascheim D.D., Casey D.E., Chung M.K., Lemos J.A., Ettinger S.M., Fang J.C., Fesmire F.M., Franklin B.A. ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation // Journal of American College of Cardiology.- 2013.- V.61(4).- P.e78-e140.
29 Roffi M., Patrono C., Collet J.P., et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC) // Eur Heart J.- 2015.- V.37(3).- P.267-315.
30 Всероссийское научное общество кардиологов. Кардиоваскулярная профилактика // Приложение 2 к журналу Кардиоваскулярная терапия профилактика. - 2011.- №10(6).- С.1-64.
31 Xin Y., Yang C., Han Z. Circulating miR-499 as a potential biomarker for acute myocardial infarction // Annual of Translational Medicine.- 2015.- V.4(7).- P.135.
32 Samanta S., Balasubramanian S., Rajasingh S., Patel U., Dhanasekaran A., Dawn B., Rajasingh J. MicroRNA: A new therapeutic strategy for cardiovascular diseases // Trends Cardiovas Med.- 2016.- V.26(5).- P.407-419.
33 Chaturvedi A., Martz R., Dorward D., Waisberg M., Pierce S.K. Endocytosed BCRs sequentially regulate MAPK and Akt signaling pathways from intracellular compartments // Natural Immunology.- 2011.- V.12(11).- P.1119-1126.
34 Li Y., Li A., Yang Z.Q. Molecular cloning, genomic organization, chromosome mapping, tissues expression pattern and identification of a novel splicing variant of porcine CIDEb gene // Biochem Biophys Res Commun.- 2016.- V.1.- P.S0006-291X(16)30778-1.
35 Ai J., Zhang R., Li Y., Pu J., Lu Y., Jiao J. Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction // Biochem Biophys Res Commun.- 2010.- V.391(1).- P.73-77.
36 Alessandra Y.D., Devanna P., Limana F., Straino S., Carlo A.D., Brambilla P.G. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction // Eur Heart J.- 2010.- V.31(22).- P.2765-2773.
37 Yin C., Salloum F.N., Kukreja R.C. A novel role of microRNA in late preconditioning: upregulation of endothelial nitric oxide synthase and heat shock protein 70 // Circ Res.- 2009.- V.104(5).- P.572-575.
38 Иващенко А.Т., Атамбаева Ш.А., Ниязова Р.Е., Пинский И.В. Гены, связанные с развитием ишемической болезни сердца // Вестник КазНУ, серия биологическая.- 2015.- №3 (65). - C. 100-108.
39 Ivashchenko A., Berillo O., Pyrkova A., Niyazova R. Binding Sites of miR-1273 Family on the mRNA of Target Genes // Biomed Research International.- 2014.- V.2014.- P.1-11.
40 Ivashchenko A., Berillo O., Pyrkova A., Niyazova R., Atambayeva S. The properties of binding sites of miR-619-5p, miR-5095, miR-5096 and miR-5585-3p in the mRNAs of human genes // Biomed Research International.- 2014.- V.2014.- P.1-8.
41 Ivashchenko A., Berillo O., Pyrkova A., Niyazova R., Atambayeva S. MiR-3960 binding sites with mRNA of human genes // Bioinformation.- 2014.- V.10(7).- P.423-427.
42 Ivashchenko A., Berillo O., Pyrkova A., Niyazova R., Atambayeva S. The binding sites of unique miRNAs in the human mRNAs // Journal of Biotechnology.- 2014.- V.185S.- P.S37–S125.
43 Атамбаева С., Ниязова Р.Е., Берилло О., Иващенко А.Т. Особенности сайтов связывания mir-574-5р и mir-574-3р с mrna генов-мишеней // Вестник КазНУ, биологическая серия.- 2015.- №1(63).- С.349-354.
References
1 Trenkwalder T, Kessler T, Schunkert H, Erdmann J (2015) Genetics of coronary artery disease: Short people at risk?, Expert Review of Cardiovascular Therapy, 13(11):1169-1172. DOI: 10.1586/14779072.2015.1094377
2 Arbour L, Asuri S, Whittome B, Polanco F, Hegele RA (2015) The Genetics of Cardiovascular Disease in Canadian and International Aboriginal Populations, Can J Cardiol, 31(9):1094-1115. DOI: 10.1016/j.cjca.2015.07.005
3 Brænne I, Civelek M, Vilne B (2015) Prediction of Causal Candidate Genes in Coronary Artery Disease Loci, Arteriosclerosis, Thrombosis, and Vascular Biology, 35(10):2207-2217. DOI: 10.1161/ATVBAHA.115.306108
4 Hamrefors V (2015) Common genetic risk factors for coronary artery disease: new opportunities for prevention?, Clin Physiol Funct I, 17:128-141. DOI: 10.1111/cpf.12289
5 Cole CB, Nikpay M, Stewart AF, McPherson R (2016) Increased genetic risk for obesity in premature coronary artery disease, Eur J Hum Genet, 29:53-69. DOI: 10.1038/ejhg.2015.162
6 Yamada Y, Matsui K, Takeuchi I, Fujimaki T (2015) Association of genetic variants with coronary artery disease and ischemic stroke in a longitudinal population-based genetic epidemiological study, Biomedical Reports, 3(3):413-419. DOI: 10.3892/br.2015.440.
7 Ozaki K, Tanaka T (2016) Molecular genetics of coronary artery disease, J Hum Genet , 61: 71–77. DOI:10.1038/jhg.2015.70
8 Neelankavil J, Rau CD, Wang Y (2015) The Genetic Basis of Coronary Artery Disease and Atrial Fibrillation: A Search for Disease Mechanisms and Therapeutic Targets, J Cardiothor Vasc An, 29(5):1328-1332. DOI: 10.1053/j.jvca.2015.01.031
9 Hernesniemi JA, Lyytikäinen LP, Oksala N, Seppälä I, Kleber ME, Mononen N, März W, Mikkelsson J, Pessi T, Louhelainen AM, Martiskainen M, Nikus K, Klopp N, Waldenberger M, Illig T, Kähönen M, Laaksonen R, Karhunen PJ, Lehtimäki T (2015) Predicting sudden cardiac death using common genetic risk variants for coronary artery disease, Eur Heart J, 36(26):1669-1675. DOI: 10.1093/eurheartj/ehv106
10 Cheng Y, An B, Jiang M, Xin Y, Xuan S (2015) Association of Tumor Necrosis Factor-alpha Polymorphisms and Risk of Coronary Artery Disease in Patients With Non-alcoholic Fatty Liver Disease, Hepat Mon, 15(3):e26818. DOI: 10.5812/hepatmon.26818
11 Liao B, Cheng K, Dong S, Liu H, Xu Z (2015) Effect of apolipoprotein A1 genetic polymorphisms on lipid profiles and the risk of coronary artery disease, Diagn Pathol, 10:102. DOI: 10.1186/s13000-015-0328-7
12 Cui F, Li K, Li Y, Zhang X, An C (2014) Apolipoprotein C3 genetic polymorphisms are associated with lipids and coronary artery disease in a Chinese population, Lipids Health Dis, 13:170. DOI: 10.1186/1476-511X-13-170
13 Arslan S, Korkmaz Ö, Özbilüm N, Berkan Ö (2015) Association between NF-κBI and NF-κBIA polymorphisms and coronary artery disease, Biomedical Reports, 3(5):736-740. DOI: 10.3892/br.2015.499
14 Ahmadi Z, Senemar S, Toosi S, Radmanesh S (2015) The Association of Lipoprotein Lipase Genes, HindIII and S447X Polymorphisms With Coronary Artery Disease in Shiraz City, Jounal of Cardiovascular and Thoracic Research, 7(2):63-67. DOI: 10.15171/jcvtr.2015.14
15 Xiao J, Luo X, Lin H, Zhang Y, Lu Y, Wang N, Zhang Y, Yang B, Wang Z (2011) MicroRNA miR-133 represses HERG K+ channel expression contributing to QT prolongation in diabetic hearts, J Biol Chem, 282(17):12363-12367. DOI: 10.1074/jbc.C700015200
16 Shan H, Zhang Y, Cai B, Chen X, Fan Y, Yang L, Chen X, Liang H, Zhang Y, Song X, Xu C, Lu Y, Yang B, Du Z (2013) Upregulation of microRNA-1 and microRNA-133 contributes to arsenic-induced cardiac electrical remodeling, Int J Cardiol, 167(6):2798-2805. DOI: 10.1016/j.ijcard.2012.07.009
17 Luo X, Lin H, Pan Z, Xiao J, Zhang Y, Lu Y, Yang B, Wang Z (2008) Down-regulation of miR-1/miR-133 contributes to re-expression of pacemaker channel genes HCN2 and HCN4 in hypertrophic heart, J Biol Chem, 283(29):20045-20052. DOI: 10.1074/jbc.M801035200
18 Wang N, Zhou Z, Liao X, Zhang T (2009) Role of microRNAs in cardiac hypertrophy and heart failure, International Union of Biochemistry and Molecular Biology Life, 61(6):566-571. DOI: 10.1002/iub.204
19 Ye Y, Perez-Polo JR, Qian J, Birnbaum Y (2011) The role of microRNA in modulating myocardial ischemia-reperfusion injury, Physiol Genomics, 43(10):534-542. DOI: 10.1152/physiolgenomics.00130.2010
20 Ono K, Kuwabara Y, Han J (2011) MicroRNAs and cardiovascular diseases, FEBS J, 278(10):1619-1633. DOI: 10.1111/j.1742-4658.2011.08090.x
21 Papoutsidakis N, Deftereos S, Kaoukis A, Bouras G, Giannopoulos G, Theodorakis A, Angelidis C, Hatzis G, Stefanadis C (2013) MicroRNAs and the heart: small things do matter, Curr Top Med Chem, 13(2):216-230. DOI: 10.2174/1568026611313020009
22 Camm AJ, Luscher TF, Serruys P (2009) The ESC Textbook of Cardiovascular Medicine, second edition. Oxford Academy, Great Britain. ISBN: 0-19-956699-2
23 Aulik IV (1990) The determination of physical working capacity in clinic and sport [Opredelenie fizicheskoi rabotosposobnosti v klinike i sporte]. Medicina, Moscow, Russia. (In Russian)
24 Babushkina GV, Kartelishev AV (2015) Low-intensive laser therapy [Nizkointensivnaia lazernaia terapiia]. «Tekhnika», Moscow. (In Russian)
25 Paciaroni M, Bogousslavsky J (2009) How did stroke become of interest to neurologists?: a slow 19th century saga, Neurology, 73(9):724-728. DOI: 10.1212/WNL.0b013e3181b59c1a
26 Subramaniam A, Shanmugam M K, Perumal E, Li F, Nachiyappan A, Dai X, Swamy SN, Ahn KS, Kumar AP, Tan BK, Hui KM, Sethi G (2013) Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma, Biochim Biophys Acta, 1835(1):46-60. DOI: 10.1016/j.bbcan.2012.10.002
27 Batishcheva EI, Kuznetsov AN (2008) Modern methods of surgical secondary prevention of ischemic stroke. Journal of N. I. Pirogov’s National Medical and Surgical Center [Sovremennye metody hirurgicheskoi vtorichnoi profilaktici ishemicheskogo insulta. Vestnik Natsional'nogo mediko-khirurgicheskogo tsentra imeni N. I. Pirogova] 3(2):83-88. (In Russian)
28 O'Gara PT, Kushner FG, Ascheim DD, Casey DE, Chung MK, Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA (2013) ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation, Journal of American College of Cardiology, 61(4):e78-e140. DOI:10.1016/j.jacc.2012.11.019
29 Roffi M, Patrono C, Collet JP, et al (2015) ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Eur Heart J, 37(3):267-315. DOI: 10.1093/eurheartj/ehv320
30 Vserossiiskoe nauchnoe obshchestvo kardiologov (2011) Cardiovascular profilactic. Supplement 2 to the journal «Cardiovascular terapy and profilactic» [Kardiovascular profilactika. Prilozheniye k zhurnalu “Serdechno-sosudistaya terapiya I profilactika] 10(6):1-64. (In Russian)
31 Xin Y, Yang C, Han Z (2016) Circulating miR-499 as a potential biomarker for acute myocardial infarction, Annual of Translational Medicine, 4(7):135. DOI: 10.21037/atm.2016.03.40
32 Samanta S, Balasubramanian S, Rajasingh S, Patel U, Dhanasekaran A, Dawn B, Rajasingh J (2016) MicroRNA: A new therapeutic strategy for cardiovascular diseases, Trends Cardiovas Med, 26(5):407-19. DOI: 10.1016/j.tcm.2016.02.004
33 Chaturvedi A, Martz R, Dorward D, Waisberg M, Pierce SK (2011) Endocytosed BCRs sequentially regulate MAPK and Akt signaling pathways from intracellular compartments, Natural Immunology, 12(11):1119-1126. DOI: 10.1038/ni.2116
34 Li Y, Li A, Yang ZQ (2016) Molecular cloning, genomic organization, chromosome mapping, tissues expression pattern and identification of a novel splicing variant of porcine CIDEb gene, Biochem Biophys Res Commun, 1:S0006-291X(16)30778-1. DOI: 10.1016/j.bbrc.2016.05.079
35 Ai J, Zhang R, Li Y, Pu J, Lu Y, Jiao J (2010) Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction, Biochem Biophys Res Commun, 391(1):73-77. DOI: 10.1016/j.bbrc.2009.11.005
36 Alessandra YD, Devanna P, Limana F, Straino S, Carlo AD, Brambilla PG (2010) Circulating microRNAs are new and sensitive biomarkers of myocardial infarction, Eur Heart J, 31(22):2765-2773. DOI: 10.1093/eurheartj/ehq167
37 Yin C, Salloum FN, Kukreja RC (2009) A novel role of microRNA in late preconditioning: upregulation of endothelial nitric oxide synthase and heat shock protein 70, Circ Res, 104(5):572-575. DOI: 10.1161/CIRCRESAHA.108.193250
38 Ivashchenko A, Atambayeva S, Niyazova R, Pinsky I (2015) Genes associated with the development of of coronary heart disease. Vestnik KazNU, biological series [Geny svyazannye s razvitiem ishemicheskoi bolezni serdtca. Vestnik KazNU, biologicheskaya seriya] 3(65):100-108. (In Russian)
39 Ivashchenko A, Berillo O, Pyrkova A, Niyazova R (2014) Binding Sites of miR-1273 Family on the mRNA of Target Genes, Biomed Research International, 2014:1-11. DOI:10.1155/2014/620530
40 Ivashchenko A, Berillo O, Pyrkova A, Niyazova R, Atambayeva S (2014) The properties of binding sites of miR-619-5p, miR-5095, miR-5096 and miR-5585-3p in the mRNAs of human genes, Biomed Research International, 2014:1-8. DOI: 10.1155/2014/720715
41 Ivashchenko A, Berillo O, Pyrkova A, Niyazova R, Atambayeva S (2014) MiR-3960 binding sites with mRNA of human genes, Bioinformation, 10(7):423-427. DOI: 10.6026/97320630010423
42 Ivashchenko A, Berillo O, Pyrkova A, Niyazova R, Atambayeva S (2014) The binding sites of unique miRNAs in the human mRNAs, Journal of Biotechnology, 185S:S37–S125. DOI: 10.1016/j.jbiotec.2014.07.181
43 Atambayeva S, Niyazova R, Berillo O, Ivashchenko A (2015) Features of binding sites of miR-574-5p and miR-574-3p with mRNA of target genes. Vestnik KazNU, biological series [Osobennosti saitov svyazyvaniya miR-574-5р i miR-574-3р s mRNA genov-mishenei. Vestnik KazNU, biologicheskaya seriya] 1(63):349-354. (In Russian)
Downloads
How to Cite
Ivashchenko, A. T., Niyazova, R. Y., Atambayeva, S. A., Pyrkova, A. Y., Pinsky, I. V., Alybayeva, A. Z., Akimniyazova, A. N., & Mamirova, A. A. (2016). microRNAs and mRNAs genes associated with the development of ischemic heart disease. Experimental Biology, 68(3), 166–177. Retrieved from https://bb.kaznu.kz/index.php/biology/article/view/1213
Issue
Section
МOLECULAR BIOLOGY AND GENETICS
